Zura Bio Limited Class A Ordinary Shares (ZURA)
Healthcare
Biotechnology
5.40 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Zura Bio Limited Class A Ordinary Shares (ZURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -65 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -1.1 | -1.2 | -15 | -28 | -65 | |
| – | – | 0.0 | 0.0 | 0.0 | |
| – | 0.3 | 9.7 | 17 | 12 | |
| 45 | 23 | – | – | – | |
| -0.2 | 3.5 | 5.1 | 2.3 | -3.6 | |
| 0.0 | 12 | 8.0 | 0.1 | 0.1 | |
| -139 | -12 | -8.0 | -5.1 | -0.1 | |
| 8.3 | 8.3 | -10 | 0.0 | – | |
| 141 | 15 | 121 | 110 | -2.2 | |
| 0.7 | 1.6 | 98 | 77 | -67 | |
| -1.1 | -13 | -23 | -28 | -65 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.